Visual inspection of drug product bag for Phase I/II CT program
A BioPhorum member only survey from the BioPhorum Commercialization workstream. The purpose of the survey was to understand what the current industry standard is for visual inspection of final drug product bag for Phase I/II autologous/allogeneic cell therapy programs.
I don't have access to this document
Make a selection below and submit your request. We will get back to you ASAP.
My company would like to become a member
If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.